Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R J WALSH

Showing results (71-80 of 79) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 79 results.
Journal of Medicinal Chemistry|February 1, 1987
Antitumor imidazotetrazines. 14. Synthesis and antitumor activity of 6- and 8-substituted imidazo[5,1-d]-1,2,3,5-tetrazinones and 8-substituted pyrazolo[5,1-d]-1,2,3,5-tetrazinonesE Lunt, C G Newton, C Smith, et al.
Journal of Medicinal Chemistry|August 16, 1996
New low-density lipoprotein receptor upregulators acting via a novel mechanismM J Ashton, T J Brown, G Fenton, et al.
Studies in Health Technology and Informatics|December 8, 1997
Training environment for inferior vena caval filter placementJ K Hahn, R Kaufman, A B Winick, et al.
Journal of Medicinal Chemistry|October 2, 1992
Synthesis and biological activity of trans(+-)-N-methyl-2-(3-pyridyl)-2-tetrahydrothiopyrancarbothioamide 1-oxide (RP 49356) and analogues: a new class of potassium channel openerT J Brown, R F Chapman, D C Cook, et al.
Genes and Immunity|September 2, 2011
Relationship between disease activity and type 1 interferon- and other cytokine-inducible gene expression in blood in dermatomyositis and polymyositisS A Greenberg, B W Higgs, C Morehouse, et al.
Journal of Medicinal Chemistry|July 21, 1998
Selective endothelin A receptor antagonists. 3. Discovery and structure-activity relationships of a series of 4-phenoxybutanoic acid derivativesP C Astles, C Brealey, T J Brown, et al.
Journal of Medicinal Chemistry|March 15, 2000
Selective ET(A) antagonists. 5. Discovery and structure-activity relationships of phenoxyphenylacetic acid derivativesP C Astles, T J Brown, F Halley, et al.
ESMO Open|March 11, 2025
Pathogenic germline variants in cancer predisposition genes in patients with multiple primary cancers in an Asian population and the role of extended panel genetic testingS W Cheo, J J Zhao, P Y Ong, et al.
ESMO Open|June 4, 2024
Therapeutic applications of germline testing for cancer predisposition genes in Asia in the real worldS W Cheo, P Y Ong, S G W Ow, et al.
Pageof 8

Showing results (71-80 of 79) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
Journal of Medicinal Chemistry|February 1, 1987
Antitumor imidazotetrazines. 14. Synthesis and antitumor activity of 6- and 8-substituted imidazo[5,1-d]-1,2,3,5-tetrazinones and 8-substituted pyrazolo[5,1-d]-1,2,3,5-tetrazinonesE Lunt, C G Newton, C Smith, et al.
Journal of Medicinal Chemistry|August 16, 1996
New low-density lipoprotein receptor upregulators acting via a novel mechanismM J Ashton, T J Brown, G Fenton, et al.
Studies in Health Technology and Informatics|December 8, 1997
Training environment for inferior vena caval filter placementJ K Hahn, R Kaufman, A B Winick, et al.
Journal of Medicinal Chemistry|October 2, 1992
Synthesis and biological activity of trans(+-)-N-methyl-2-(3-pyridyl)-2-tetrahydrothiopyrancarbothioamide 1-oxide (RP 49356) and analogues: a new class of potassium channel openerT J Brown, R F Chapman, D C Cook, et al.
Genes and Immunity|September 2, 2011
Relationship between disease activity and type 1 interferon- and other cytokine-inducible gene expression in blood in dermatomyositis and polymyositisS A Greenberg, B W Higgs, C Morehouse, et al.
Journal of Medicinal Chemistry|July 21, 1998
Selective endothelin A receptor antagonists. 3. Discovery and structure-activity relationships of a series of 4-phenoxybutanoic acid derivativesP C Astles, C Brealey, T J Brown, et al.
Journal of Medicinal Chemistry|March 15, 2000
Selective ET(A) antagonists. 5. Discovery and structure-activity relationships of phenoxyphenylacetic acid derivativesP C Astles, T J Brown, F Halley, et al.
ESMO Open|March 11, 2025
Pathogenic germline variants in cancer predisposition genes in patients with multiple primary cancers in an Asian population and the role of extended panel genetic testingS W Cheo, J J Zhao, P Y Ong, et al.
ESMO Open|June 4, 2024
Therapeutic applications of germline testing for cancer predisposition genes in Asia in the real worldS W Cheo, P Y Ong, S G W Ow, et al.
Pageof 8